Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 84

HawkEye 360 hooks $55m in series C

Esri helped the satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.

Apr 13, 2021

Salesforce joins Community with $40m investment

Salesforce has supplied additional funding for the text messaging platform operator, which is also backed by Sony, Live Nation and Twilio.

Apr 12, 2021

Groww reaches unicorn status in $83m series D

The online investment platform developer was valued at over $1bn in a series D round backed by BBVA’s Propel Venture Partners.

Apr 9, 2021

Tripledot gets a grip on $78m

Mobile puzzle game developer Tripledot Studios has bagged series A funding from investors including Access Industries.

Apr 9, 2021

ValenzaBio balances $70m in series A

The Pierre Fabre-backed antibody therapy developer has closed a series A round featuring new and founding investors.

Apr 9, 2021

Metagenomi magnifies series A to $75m

UC Berkeley's DNA-editing technology spinout has raised $10m from RA Capital in addition to the $65m it pocketed in November.

Apr 9, 2021

Canva captures $71m at $15bn valuation

T Rowe Price and Dragoneer co-led a round that pushed the VaynerMedia-backed design software provider's overall funding past $350m.

Apr 8, 2021

TrueLayer accrues $70m in series D round

The opemn banking software provider almost doubled its overall funding to $142m in a round featuring Santander-backed Mouro Capital.

Apr 8, 2021

Pendulum Therapeutics swings to $54m series C

Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.

Apr 8, 2021

Metagenomi magnifies series A to $75m

The DNA-editing technology developer has raised $10m in addition to the $65m it pulled in from investors including Leaps by Bayer in November.

Apr 8, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here